| GSVA: gene set variation analysis for microarray and RNA-seq data S Hänzelmann, R Castelo, J Guinney BMC bioinformatics 14, 1-15, 2013 | 10175 | 2013 |
| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 4924 | 2015 |
| The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4832 | 2018 |
| Genome-wide methylation profiles reveal quantitative views of human aging rates G Hannum, J Guinney, L Zhao, LI Zhang, G Hughes, SV Sadda, B Klotzle, ... Molecular cell 49 (2), 359-367, 2013 | 3561 | 2013 |
| AACR Project GENIE: powering precision medicine through an international consortium AACR Project Genie Consortium, AACR Project GENIE Consortium, ... Cancer discovery 7 (8), 818-831, 2017 | 1420 | 2017 |
| Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer R Dienstmann, L Vermeulen, J Guinney, S Kopetz, S Tejpar, J Tabernero Nature reviews cancer 17 (2), 79-92, 2017 | 1017 | 2017 |
| The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment MA Haendel, CG Chute, TD Bennett, DA Eichmann, J Guinney, WA Kibbe, ... Journal of the American Medical Informatics Association 28 (3), 427-443, 2021 | 475 | 2021 |
| F-Seq: a feature density estimator for high-throughput sequence tags AP Boyle, J Guinney, GE Crawford, TS Furey Bioinformatics 24 (21), 2537-2538, 2008 | 444 | 2008 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 441 | 2020 |
| Key parameters of tumor epitope immunogenicity revealed through a consortium approach improve neoantigen prediction DK Wells, MM van Buuren, KK Dang, VM Hubbard-Lucey, KCF Sheehan, ... Cell 183 (3), 818-834. e13, 2020 | 406 | 2020 |
| Evaluation of combined artificial intelligence and radiologist assessment to interpret screening mammograms T Schaffter, DSM Buist, CI Lee, Y Nikulin, D Ribli, Y Guan, W Lotter, Z Jie, ... JAMA network open 3 (3), e200265-e200265, 2020 | 379 | 2020 |
| Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes FA Sinicrope, Q Shi, TC Smyrk, SN Thibodeau, R Dienstmann, J Guinney, ... Gastroenterology 148 (1), 88-99, 2015 | 377 | 2015 |
| Evidence for type II cells as cells of origin of K-Ras–induced distal lung adenocarcinoma X Xu, JR Rock, Y Lu, C Futtner, B Schwab, J Guinney, BLM Hogan, ... Proceedings of the National Academy of Sciences 109 (13), 4910-4915, 2012 | 342 | 2012 |
| Combining tumor genome simulation with crowdsourcing to benchmark somatic single-nucleotide-variant detection AD Ewing, KE Houlahan, Y Hu, K Ellrott, C Caloian, TN Yamaguchi, ... Nature methods 12 (7), 623-630, 2015 | 336 | 2015 |
| Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen MP Menden, D Wang, MJ Mason, B Szalai, KC Bulusu, Y Guan, T Yu, ... Nature communications 10 (1), 2674, 2019 | 310 | 2019 |
| American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine MW Kattan, KR Hess, MB Amin, Y Lu, KGM Moons, JE Gershenwald, ... CA: a cancer journal for clinicians 66 (5), 370-374, 2016 | 300 | 2016 |
| Inferring causal molecular networks: empirical assessment through a community-based effort SM Hill, LM Heiser, T Cokelaer, M Unger, NK Nesser, DE Carlin, Y Zhang, ... Nature methods 13 (4), 310-318, 2016 | 258 | 2016 |
| Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ... Annals of Oncology 28 (5), 1023-1031, 2017 | 244 | 2017 |
| Colorectal cancer consensus molecular subtypes translated to preclinical models uncover potentially targetable cancer cell dependencies A Sveen, J Bruun, PW Eide, IA Eilertsen, L Ramirez, A Murumägi, ... Clinical Cancer Research 24 (4), 794-806, 2018 | 243 | 2018 |
| Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data IS Jang, EC Neto, J Guinney, SH Friend, AA Margolin Biocomputing 2014, 63-74, 2014 | 242 | 2014 |
